Aimmune Therapeutics Inc

FDA Filings

This page includes the latest FDA filings for Aimmune Therapeutics Inc. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.

USANASDAQAIMTDUNS 057562771
FDA Registration(s)

FDA Filings

Device
Company
DeviceDate
Aimmune Therapeutics, Inc.
Prescription Medication2024-05-22
Aimmune Therapeutics, Inc.
Prescription Medication2024-03-15
Aimmune Therapeutics, Inc.
Prescription Medication2023-11-10
Aimmune Therapeutics, Inc.
Prescription Medication2023-10-21
Aimmune Therapeutics, Inc., Seres Therapeutics, Inc.
Prescription Medication2023-05-05
Aimmune Therapeutics, Inc.
Prescription Medication2021-11-10
Aimmune Therapeutics, Inc.
Prescription Medication2021-01-01

Similar & Related FDA Registered Companies

Related Finance Registrations
NCAGE Code8H6R2AIMMUNE THERAPEUTICS, INC.
CAGE Code8H6R2AIMMUNE THERAPEUTICS, INC.
S.A.M. Registration8H6R2 [57562771]AIMMUNE THERAPEUTICS, INC.
SEC0001631650Aimmune Therapeutics, Inc. of DELAWARE
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.